I am still very on the fence on this since the Adcom. I hope we all make money when the decision arrives
MarkyBoy212
на прошлой неделе
A new buy rating and 2 maintained buys very nice
A new buy rating and 2 maintained buys very nice, hoping this gets approval after earnings and award
ByronKS
на прошлой неделе
Capricor earnings report
See the Capricor Therapeutics earnings report below. Good luck! 🤞🏼🍀
https://web.quartr.com/link/companies/5913/events/732825/report?rp=0&documentId=4012432
MarkyBoy212
2 недели назад
Capricor’s HOPE-3 Phase 3 Cardiac Results for Deramiocel Win American Heart Association Outstanding Research Award in Pediatric Cardiology
Capricor’s HOPE-3 Phase 3 Cardiac Results for Deramiocel Win American Heart Association Outstanding Research Award in Pediatric Cardiology
TerraNova23
2 недели назад
Anyone else think this will fail?
According to Adam Feuerstein, Capricor faces two major risks:
Weak Clinical Evidence: The FDA may consider Deramiocel's efficacy data insufficient for approval.
Public Pressure on the FDA: Capricor's public statements could suggest concerns about its chances of approval.
And there is still the 3-9 vote from before.
Capricor Therapeutics to Present HOPE-3 and HOPE-3 Open-Label Extension Data at 2026 World Muscle Society Congress
Prayers
3 месяца назад
This too (and yh I DO wish I did this in CFD lol)
GGGGM
3 месяца назад
Thank God for this stock today
$CAPR to the rescue, thank you thus far... NFA
kosen
3 месяца назад
This pattern looks exactly like yesterday.
If it completely duplicates yesterday’s pattern, we see 11.5 Today???
kosen
3 месяца назад
What do we think
At a loss now, watching a bit
GGGGM
3 месяца назад
We going up.. The News is here.. NFA.
$CAPR would soar today as the long awaited news is finally here.
The FDA accepted a major amendment to Capricor's Biologics License Application (BLA) containing 24-month Phase 3 HOPE-3 extension data. Instead of issuing an immediate rejection, the FDA extended the PDUFA target action date to November 22, 2026.
I got in early at $8 and waiting to see above 11 and above..
Note that THIS IS NOT A FINANCIAL ADVICE... NFA
SKM2086
3 месяца назад
PT - $54
I'm going with a conservative $25-30. We're on the right track now. Definitely close to making permanent moves upwards.
https://uk.investing.com/news/stock-market-news/oppenheimer-upgrades-capricor-stock-rating-on-regulatory-update-93CH-4846076
MarkyBoy212
3 месяца назад
Capricor Therapeutics Announces Extension of PDUFA Target Action Date as FDA Continues Review of Deramiocel BLA
Capricor Therapeutics Announces Extension of PDUFA Target Action Date as FDA Continues Review of Deramiocel BLA nice news guys
Hazlaw1234
3 месяца назад
$CAPR feels like one to watch very closely today 👀
The official PDUFA target date is tomorrow, Saturday 22 August, but with that falling on a weekend there’s a very real possibility we hear something from the FDA today instead.
As of now there’s been no decision announced, so I’d expect a lot of eyes on CAPR once the US session gets going and especially into after hours.
Could be a very important day for the stock. Definitely worth keeping notifications on.
NFA
Эта страница может содержать созданный группой контент, за который Trading 212 не несет ответственности. Всегда проводите собственные исследования. Trading 212 предоставляет услуги только по исполнению и не предлагает инвестиционные консультации или управление портфолио.
Создание богатства – это привычка. Автоматизируйте ее с помощью пая.
Инвестируйте в готовые паи или создавайте свои собственные, выбирая из тысяч акций и ETF
Подробнее
Подробнее
Смотреть видео
Становитесь владельцами самых дорогих акций, таких как Google, Amazon и Apple
Смотреть видео
Euronext Paris
NYSE, NASDAQ
Xetra, Gettex
Euronext Amsterdam
Bolsa de Madrid
Wiener Börse
Лондонская фондовая биржа
Euronext Лиссабон
Euronext Paris
NYSE, NASDAQ
Xetra, Gettex
Euronext Amsterdam
Bolsa de Madrid
Wiener Börse
Лондонская фондовая биржа
Euronext Лиссабон
Смотреть все торговые инструменты
Поддержка клиентов 24/7
Среднее время ответа - 29 секунд
Начните создавать богатство сейчас
Станьте одним из 5 миллионам пользователей
Получить приложение
Открыть счёт
Получите мобильное приложение
Все представленные статистические данные являются глобальными. Количество клиентов представляет собой количество финансируемых Счетов.
Отлично
Оценка 4,6 / 5 на основании 108 764 обзоров на
Trustpilot
Оценка 4,6 / 5 на основании 108 764 обзоров на
Trustpilot
Приглашен(-а)
Great app very easy to use and lots of…
Great app very easy to use and lots of information. Always upto date with balances and share prices etc.
Приглашен(-а)
Smooth experience
The whole thing is smooth and seamless and makes things easy overall.
Приглашен(-а)
Really easy to use
Really easy to use. Secure and has the best functionality and features.
Приглашен(-а)
Easy to keep up with as informed…
Easy to keep up with as informed everyday or week on interest made . Easy to set up account . No problems .
Приглашен(-а)
Easy to operate and work with
Easy to operate and work with. Works very fast and accurately.
Приглашен(-а)
How you rate the app
This app is so easy to use and safe really love it.
Приглашен(-а)
I opened a cash ISA with them
I opened a cash ISA with them. It was really straightforward to do and interest is added daily. Nice ,easy to use app as well.
Приглашен(-а)
Easy to navigate makes investing…
Easy to navigate makes investing interesting, transferred my investments from HL which was very straightforward and now not paying dealing fee’s
Very Happy
Приглашен(-а)
App is easy to work
App is easy to work
Good interest rate
Daily interest updates
Приглашен(-а)
Very good and informative always stay…
Very good and informative always stay on track with your investments
Приглашен(-а)
Reliable
Reliable, trustworthy app to store your money and to build on your existing wealth if you are financially sensible and smart.
Приглашен(-а)
Great app
Great app. I would recommend to anyone that’s into investing and making their money grow .
Приглашен(-а)
Very easy app to register and use
Very easy app to register and use! Really pleased.
Приглашен(-а)
Clear app
Clear app. Easy to invest. Took a whike for money to get in because i did it from bank rather than in app
Приглашен(-а)
Very smooth and user friendly
Very smooth and user friendly. Have had zero issues having moved from other brokerages. Will keep using.
Приглашен(-а)
Easy to set up and to regular monitor…
Easy to set up and to regular monitor how its performing.
Приглашен(-а)
Competitive rates and quick transfers
Very good on money transfers in and out. They take place immediately unlike some other providers.
Very competitive rate on Cash ISA
Приглашен(-а)
Customer support is quick and…
Customer support is quick and effective. The app is well organised and easy to use. Would reccommend for anyone even complete beginners.
Приглашен(-а)
Easy to set up the Cash ISA
Easy to set up the Cash ISA, funds arrived in account almost immediately. Great to see interest accrual amounts daily.
Приглашен(-а)
Reliable
Reliable, Secure. Using it for past 3 years
Показаны некоторые положительные отзывы наших клиентов
Наши награды
Часто задаваемые вопросы
Какова цена акций Capricor Therapeutics?
Текущая цена Capricor Therapeutics составляет 7,59 $.